Q-omics provides the consensus-scored MIR3171 profile across patient tissues and cancer cell-line models. MIR3171 expression is associated with patient survival in 7 of 34 cancer types, with the highest sampling consensus in COAD. Among the 18 cancer types available for tumor–normal comparison, MIR3171 is differentially expressed in 1, with the highest sampling consensus in KIRC. Additionally, MIR3171 RNA expression shows 4,336 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight COAD, KIRC, and ESCA as cancer lineages where MIR3171 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR3171 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR3171 survival associations across molecular data types. MIR3171 RNA expression shows survival associations in the most cancer types (7). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR3171 RNA expression–survival associations across cancer types. High MIR3171 expression shows unfavorable associations in COAD, LIHC, LUSC, SARC and STAD, but favorable associations in ESCA. The COAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify COAD as the clearest survival context for MIR3171 RNA expression.
This table summarizes MIR3171 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for MIR3171. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR3171 shows lower tumor expression in KIRC. The KIRC box plot shows higher MIR3171 RNA expression in normal versus tumor tissue (log2 FC = −0.105, t-test p = .006).
This table shows molecular features associated with MIR3171 in patient tissues and cancer cell lines. In patient samples, MIR3171 shows the broadest associations at the RNA and protein expression levels, with ESCA recurring as the lineage with the largest associated feature set.
